Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Pension (2019 - 2023)

ADC Therapeutics has reported Pension over the past 5 years, most recently at $11.1 million for Q4 2023.

  • Quarterly results put Pension at $11.1 million for Q4 2023, down 12.49% from a year ago — trailing twelve months through Dec 2023 was $11.1 million (down 12.49% YoY), and the annual figure for FY2023 was $11.1 million, down 12.49%.
  • Pension reached $11.1 million in Q4 2023 per ADCT's latest filing, down from $12.7 million in the prior quarter.
  • Across five years, Pension topped out at $15.3 million in Q4 2021 and bottomed at $2684.0 in Q4 2019.
  • Median Pension over the past 5 years was $3.6 million (2021), compared with a mean of $4.8 million.
  • The largest annual shift saw Pension skyrocketed 431144.71% in 2021 before it decreased 16.98% in 2022.
  • Over 5 years, Pension stood at $2684.0 in 2019, then soared by 32.0% to $3543.0 in 2020, then surged by 431144.71% to $15.3 million in 2021, then fell by 16.98% to $12.7 million in 2022, then dropped by 12.49% to $11.1 million in 2023.
  • Business Quant data shows Pension for ADCT at $11.1 million in Q4 2023, $12.7 million in Q4 2022, and $3.7 million in Q1 2022.